August 8, 2016
(Scientific American) – U.S. health regulators have cleared the way for a trial of genetically modified mosquitoes in Florida that can reduce mosquito populations, potentially offering a new tool to fight the local spread of Zika and other viruses. The U.S. Food and Drug Administration said on Friday that a field trial testing Intrexon Corp’s (XON.N) genetically engineered mosquitoes would not have a significant impact on the environment. The announcement came as Florida officials grapple with the first cases of local Zika transmission in the continental United States.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.